Latest AI and machine learning research in vaccines for healthcare professionals.
Viral diseases pose a serious threat to global public health, agriculture, and biosecurity. Conventional antiviral strategies are often limited by an incomplete understanding of disease mechanisms, poor targeting precision, and slow response times. Emerging technologies are now reshaping the landscape of antiviral research. This review examines the roles of four key frontiers, including organoid m...
RATIONALE AND OBJECTIVES: To map artificial intelligence (AI) and radiomics applications in computed tomography (CT), magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) for oropharyngeal squamous cell carcinoma (OPSCC) in the context of human papillomavirus (HPV) status and treatment deintensification, evaluate reporting quality using TRIPOD+AI (T...
BACKGROUND: Human papilloma virus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is rising. Despite the prognostic and therapeu...
BACKGROUND: Herpes zoster vaccination is recommended for U.S. adults aged 50 years and older, yet many remain unvaccinated. Prior National Health Inte...
Neoantigen vaccines have rekindled interest in therapeutic cancer vaccination, yet their clinical efficacy remains constrained by imperfect antigen pr...
Atypical glandular cells (AGC) are a diagnostic challenge. The aim of this study was to evaluate the efficacy and diagnostic performance of AGC detect...
Endocervical gastric-type adenocarcinoma (GAS) is one of the most aggressive subtypes of cervical cancer and is frequently underdiagnosed due to morph...
Personalized neoantigen cancer vaccine is a promising strategy for precision immunotherapy by targeting patient-specific and mutation-derived tumor an...
Microphysiological immune-on-chip systems have emerged as transformative biomedical microdevices capable of recreating the structural, biochemical, an...
The global emergence of monkeypox virus (MPXV) has created an urgent need for effective vaccines that induce robust immune responses. Here, we report ...
Vaccination remains among the most effective public health interventions, but its impact increasingly depends on public trust and a reliable informati...
Cancer vaccines are emerging as a promising approach in immuno-oncology, with the potential to generate tumour-specific and long-lasting immune respon...
The sixth modeling workshop (6MW) was held in June 2025 at Collegeville, Pennsylvania, USA, and supported by the Recovery of Biological Products Confe...
OBJECTIVE: Community resilience during COVID-19 has been linked to social conditions, public-health capacity, and acute-care resources, but the contri...
Neoantigens are tumor-specific antigens resulting from genetic, transcriptomic, and proteomic changes, making them a promising avenue for personalized...
BACKGROUND: Since the emergence of the COVID-19 pandemic, co-infection with COVID-19 and influenza has been associated with adverse health and economi...
Secondary use is now the ordinary condition of data science health research rather than an exception to it. Electronic health records collected for cl...
Artificial intelligence has accelerated epitope and antigen discovery, but prediction alone cannot determine vaccine readiness. Translational design r...
BACKGROUND: Abstracts and Discussion sections serve distinct functions: Abstracts are optimized for brevity and impact, while Discussion sections cont...